Global Next Generation Sequencing Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Next Generation Sequencing Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples. Next generation sequencing systems can be divided by three parts, instruments, consumables and related services. At the same time, NGS also supports a wide range of applications, including gene expression profiling, chromosome counting, epigenetic change detection, and molecular analysis, which can drive discovery research and realize the bright future of personalized medicine.
Next Generation Sequencing Technology report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Next Generation Sequencing Technology market is projected to reach US$ 12360 million in 2033, increasing from US$ 4486 million in 2022, with the CAGR of 15.4% during the period of 2023 to 2033. Demand from Hospitals and Clinics and Biopharma Companies are the major drivers for the industry.
The Next Generation Sequencing (NGS) Technology market is driven by the increasing demand for personalized medicine and advancements in genomic research. NGS technology enables rapid and high-throughput DNA and RNA sequencing, offering insights into genetic variations and molecular profiles for various applications in healthcare and life sciences. The rise in genetic diseases and cancer cases contributes to market growth as researchers and clinicians seek comprehensive genetic information for diagnosis, treatment, and drug development. Moreover, technological innovations in sequencing platforms and data analysis align with improved accuracy, speed, and cost-effectiveness of sequencing processes. However, the market also faces challenges, including managing and interpreting large volumes of genomic data and addressing ethical and privacy concerns related to genetic information. Additionally, ensuring standardization and quality control in NGS workflows and navigating regulatory requirements can pose obstacles for stakeholders. To succeed, companies must focus on data analytics solutions, collaborations in multi-omics research, and addressing the challenges to meet the increasing demand for NGS technology that drives advancements in personalized medicine and genomics research.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Sequencing Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Next Generation Sequencing Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Next Generation Sequencing Technology introduction, etc. Next Generation Sequencing Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Next Generation Sequencing Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Next Generation Sequencing Technology report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Next Generation Sequencing Technology market is projected to reach US$ 12360 million in 2033, increasing from US$ 4486 million in 2022, with the CAGR of 15.4% during the period of 2023 to 2033. Demand from Hospitals and Clinics and Biopharma Companies are the major drivers for the industry.
The Next Generation Sequencing (NGS) Technology market is driven by the increasing demand for personalized medicine and advancements in genomic research. NGS technology enables rapid and high-throughput DNA and RNA sequencing, offering insights into genetic variations and molecular profiles for various applications in healthcare and life sciences. The rise in genetic diseases and cancer cases contributes to market growth as researchers and clinicians seek comprehensive genetic information for diagnosis, treatment, and drug development. Moreover, technological innovations in sequencing platforms and data analysis align with improved accuracy, speed, and cost-effectiveness of sequencing processes. However, the market also faces challenges, including managing and interpreting large volumes of genomic data and addressing ethical and privacy concerns related to genetic information. Additionally, ensuring standardization and quality control in NGS workflows and navigating regulatory requirements can pose obstacles for stakeholders. To succeed, companies must focus on data analytics solutions, collaborations in multi-omics research, and addressing the challenges to meet the increasing demand for NGS technology that drives advancements in personalized medicine and genomics research.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Sequencing Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Next Generation Sequencing Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Next Generation Sequencing Technology introduction, etc. Next Generation Sequencing Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Next Generation Sequencing Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.